A detailed history of Israel Englander (Millennium Management LLC) transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 112,699 shares of TBPH stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112,699
Previous 62,269 80.99%
Holding current value
$1.12 Million
Previous $528,000 71.97%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.66 - $10.25 $386,293 - $516,907
50,430 Added 80.99%
112,699 $908,000
Q2 2024

Aug 14, 2024

BUY
$8.29 - $9.92 $18,644 - $22,310
2,249 Added 3.75%
62,269 $528,000
Q1 2024

May 15, 2024

SELL
$8.22 - $11.59 $494,391 - $697,080
-60,145 Reduced 50.05%
60,020 $538,000
Q4 2023

Feb 14, 2024

BUY
$8.58 - $11.4 $878,557 - $1.17 Million
102,396 Added 576.26%
120,165 $1.35 Million
Q2 2023

Aug 14, 2023

SELL
$10.16 - $11.92 $1.24 Million - $1.45 Million
-121,937 Reduced 87.28%
17,769 $183,000
Q1 2023

May 15, 2023

SELL
$9.87 - $11.44 $5.29 Million - $6.13 Million
-535,784 Reduced 79.32%
139,706 $1.52 Million
Q4 2022

Feb 14, 2023

BUY
$9.65 - $11.34 $240,593 - $282,728
24,932 Added 3.83%
675,490 $7.58 Million
Q3 2022

Nov 14, 2022

BUY
$8.39 - $10.22 $5.46 Million - $6.65 Million
650,558 New
650,558 $6.6 Million
Q2 2022

Aug 15, 2022

SELL
$8.41 - $10.34 $149,740 - $184,103
-17,805 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$8.33 - $12.96 $47,381 - $73,716
-5,688 Reduced 24.21%
17,805 $170,000
Q4 2021

Feb 14, 2022

SELL
$7.42 - $11.05 $6.84 Million - $10.2 Million
-922,041 Reduced 97.52%
23,493 $260,000
Q3 2021

Nov 15, 2021

BUY
$6.77 - $14.41 $5.38 Million - $11.5 Million
794,983 Added 528.05%
945,534 $7 Million
Q2 2021

Aug 16, 2021

BUY
$14.52 - $22.46 $460,022 - $711,577
31,682 Added 26.65%
150,551 $2.19 Million
Q1 2021

May 17, 2021

BUY
$16.57 - $21.08 $1.57 Million - $1.99 Million
94,617 Added 390.14%
118,869 $2.43 Million
Q4 2020

Feb 16, 2021

BUY
$14.89 - $20.16 $112,925 - $152,893
7,584 Added 45.5%
24,252 $431,000
Q3 2020

Nov 16, 2020

BUY
$14.79 - $22.49 $246,519 - $374,863
16,668 New
16,668 $246,000
Q1 2020

May 14, 2020

SELL
$17.84 - $31.21 $1.79 Million - $3.14 Million
-100,551 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$16.12 - $25.89 $1.62 Million - $2.6 Million
100,551 New
100,551 $2.6 Million
Q2 2019

Aug 14, 2019

SELL
$15.6 - $25.15 $259,318 - $418,068
-16,623 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$22.57 - $28.15 $375,181 - $467,937
16,623 New
16,623 $377,000
Q4 2018

Feb 14, 2019

SELL
$22.52 - $35.07 $2.96 Million - $4.62 Million
-131,596 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$22.83 - $32.67 $2.02 Million - $2.89 Million
88,430 Added 204.86%
131,596 $4.3 Million
Q2 2018

Aug 14, 2018

SELL
$22.06 - $25.52 $528,513 - $611,408
-23,958 Reduced 35.69%
43,166 $979,000
Q1 2018

May 15, 2018

BUY
$23.37 - $29.71 $1.22 Million - $1.55 Million
52,086 Added 346.36%
67,124 $1.63 Million
Q4 2017

Feb 14, 2018

BUY
$25.82 - $35.66 $388,281 - $536,255
15,038
15,038 $419,000

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $666M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.